JOHNS HOPKINS HAS DEVELOPED A NEW CLINICAL TRIALS NETWORK TO BE MORE INCLUSIVE, ELIZABETH TRACEY REPORTSBALCH: There are a number of networks in the cancer area, there are a few in diabetes, and then orthopedics. I donít know of any other networks that are the broad-based type of network weíre putting together here. :12
Time was when most clinical trials, where cutting edge research is typically done, were undertaken only at academic medical centers. Such centers are often inconvenient for many potential study participants. Now Johns Hopkins has developed a research network that is attempting to include many more patients. Charles Balch, director of the Johns Hopkins Research Network, explains.
BALCH: There are several advantages to patients in the community. One is they donít have to drive to the East Baltimore campus to get innovative trials, especially those types of trials that require a lot of follow up and diagnostic monitoring. Two is it allows them with their local physician to have access to some innovative therapies or some diagnostics that otherwise they may have to drive long distances to get. :23
This network is unique, Balch says.
At Johns Hopkins, Iím Elizabeth Tracey.